microRNA information: hsa-miR-101-3p

SectionIDlink
Mature name: hsa-miR-101-3pmiRbase
Accession: MIMAT0000099miRbase
Precursor name: hsa-mir-101-1 miRbase
Precursor accession: MI0000103miRbase
Symbol: MIR101-1HGNC
RefSeq ID: NR_029516GenBank
Sequence: UACAGUACUGUGAUAACUGAA



Reported expression in cancers: hsa-miR-101-3p

miRNAcancerregulationreportingPUBMEDmethod
hsa-miR-101-3p

bladder cancerdownregulation"Here we report that the expression of microRNA-101 ......"23618864
hsa-miR-101-3p

bladder cancerdownregulation"The microRNA miR-101 is downregulated in several c ......"25658842
hsa-miR-101-3p

breast cancerdownregulation"microRNA-101 miR-101 is down-regulated in several ......"25059472qPCR
hsa-miR-101-3p

cervical and endocervical cancerdownregulation"The profiles of miRNA in cervical cancer and chron ......"24528073Microarray; qPCR; in situ hybridization
hsa-miR-101-3p

cervical and endocervical cancerdownregulation"Previously we found that miR-101 is significantly ......"26617722
hsa-miR-101-3p

chronic myeloid leukemiaderegulation"Some onco-miRNAs were found to be downregulated mi ......"25833191
hsa-miR-101-3p

colon cancerupregulation"Here we show that miR-101 expression is differenti ......"22930392
hsa-miR-101-3p

colorectal cancerdownregulation"Among the inferred candidates three miRNAs miR-101 ......"25286864
hsa-miR-101-3p

colorectal cancerdownregulation"miR-455 miR-484 and miR-101 were significantly dow ......"25355599
hsa-miR-101-3p

esophageal cancerdownregulation"To investigate the role of miR-101 in the regulati ......"25400732
hsa-miR-101-3p

gastric cancerdownregulation"MicroRNA microarray expression profiling and array ......"22450781Microarray; qPCR
hsa-miR-101-3p

gastric cancerdownregulation"In this study we reported that miR-101 is signific ......"25561270
hsa-miR-101-3p

glioblastomaupregulation"Quantitative real-time PCR showed that miR-101 exp ......"25230316qPCR
hsa-miR-101-3p

head and neck cancerderegulation"A global miRNA profiling was performed on 12 sampl ......"21637912qPCR; Microarray
hsa-miR-101-3p

liver cancerdownregulation"miR-101 a significantly down-regulated miRNA was f ......"19155302
hsa-miR-101-3p

liver cancerdownregulation"Moreover the down-regulation of miR-101 in clinica ......"23178713
hsa-miR-101-3p

liver cancerdownregulation"Based on our prior observations that miRNA-101 miR ......"24260081qPCR
hsa-miR-101-3p

liver cancerdownregulation"However the correlation between HBV and miR-101 ha ......"24697700
hsa-miR-101-3p

liver cancerdownregulation"Here we examine how HBV affects the production of ......"24788845
hsa-miR-101-3p

lung cancerdownregulation"miR 101 DNA copy loss is a prominent subtype speci ......"21849855
hsa-miR-101-3p

lung cancerdownregulation"At the same time microRNA-101 mir-101 was found to ......"25428391
hsa-miR-101-3p

lung cancerdownregulation"The deregulation of miR-101 has been implicated in ......"26628987
hsa-miR-101-3p

lung squamous cell cancerdownregulation"MiR-101 has been reported down-regulated in variou ......"21993632
hsa-miR-101-3p

lymphomadownregulation"Histone deacetylase inhibitor prevents cell growth ......"24577510Microarray
hsa-miR-101-3p

melanomadownregulation"The microRNA miR-101 has been reported to be a tum ......"23962556
hsa-miR-101-3p

pancreatic cancerupregulation"miR-101 is an outstanding tumor suppressor in vari ......"25968875
hsa-miR-101-3p

prostate cancerdownregulation"Candidate serum miRNAs were detected by using PCR ......"24477576Microarray; qPCR
hsa-miR-101-3p

retinoblastomadownregulation"miR-101 has been identified as a tumor suppressor ......"24807198
hsa-miR-101-3p

sarcomadownregulation"miR-101 is downregulated in various types of cance ......"25190211
hsa-miR-101-3p

thyroid cancerdownregulation"The results showed that miR-101 was significantly ......"24649082
hsa-miR-101-3p

thyroid cancerdownregulation"This study revealed that miR-101 is significantly ......"25202416



Reported cancer pathway affected by hsa-miR-101-3p

miRNAcancerpathwayreportingPUBMEDfunctional study
hsa-miR-101-3p

bladder cancerApoptosis pathway"Methyl jasmonate sensitizes human bladder cancer c ......"24490857Flow cytometry
hsa-miR-101-3p

bladder cancerApoptosis pathway"Enforced expression of miR 101 enhances cisplatin ......"25109742Western blot; MTT assay; Luciferase
hsa-miR-101-3p

breast cancerApoptosis pathway"miR 101 promotes breast cancer cell apoptosis by t ......"25059472MTT assay; Flow cytometry; Western blot
hsa-miR-101-3p

breast cancerApoptosis pathway"The aim of our study was to investigate the functi ......"26036638Luciferase
hsa-miR-101-3p

cervical and endocervical cancerApoptosis pathway"Although aberrant miRNA expression has been docume ......"24289600Flow cytometry; Wound Healing Assay
hsa-miR-101-3p

cervical and endocervical cancercell cycle pathway"miR 101 inhibits the G1 to S phase transition of c ......"24987920Western blot; Luciferase; Flow cytometry
hsa-miR-101-3p

cervical and endocervical cancerApoptosis pathway"Previously we found that miR-101 is significantly ......"26617722MTT assay; Flow cytometry
hsa-miR-101-3p

colon cancerEpithelial mesenchymal transition pathway"Loss of miR 101 expression promotes Wnt/β catenin ......"22930392
hsa-miR-101-3p

colorectal cancercell cycle pathway; Apoptosis pathway"Effect of miR 101 on biological characteristics of ......"27435782Colony formation; Flow cytometry
hsa-miR-101-3p

esophageal cancerApoptosis pathway"miR 101 suppresses tumor proliferation and migrati ......"25400732Flow cytometry; Wound Healing Assay
hsa-miR-101-3p

gastric cancerApoptosis pathway"Downregulation of miR 101 in gastric cancer correl ......"23013439
hsa-miR-101-3p

gastric cancercell cycle pathway"MiR 101 inhibits cell growth and tumorigenesis of ......"25561270Colony formation
hsa-miR-101-3p

glioblastomaApoptosis pathway"miR 101 acts as a tumor suppressor by targeting Kr ......"25230316Luciferase
hsa-miR-101-3p

liver cancerApoptosis pathway"miR-101 a significantly down-regulated miRNA was f ......"19155302Luciferase
hsa-miR-101-3p

liver cancerApoptosis pathway"miR 101 inhibits autophagy and enhances cisplatin ......"23483142
hsa-miR-101-3p

liver cancercell cycle pathway"Further expression analyses using a large panel of ......"23544130
hsa-miR-101-3p

liver cancercell cycle pathway; Apoptosis pathway"Oncogene polycomb group protein enhancer of zeste ......"24211739Luciferase; Colony formation
hsa-miR-101-3p

liver cancerApoptosis pathway"Functional analysis of miR 101 3p and Rap1b involv ......"24697700Luciferase
hsa-miR-101-3p

liver cancerEpithelial mesenchymal transition pathway"However the efficacy of miR-101 replacement therap ......"25693145
hsa-miR-101-3p

lung cancerApoptosis pathway"miR 101 represses lung cancer by inhibiting intera ......"26349988
hsa-miR-101-3p

lung squamous cell cancerApoptosis pathway"In this study we investigate whether miRNA miR-101 ......"21270667Luciferase
hsa-miR-101-3p

lymphomacell cycle pathway; Apoptosis pathway"MicroRNA profiles were correlated with correspondi ......"21960592
hsa-miR-101-3p

ovarian cancerApoptosis pathway"MicroRNA-101 miR-101 expression is negatively asso ......"21818714Wound Healing Assay
hsa-miR-101-3p

prostate cancerApoptosis pathway; PI3K/Akt signaling pathway"RLIP76 dependent suppression of PI3K/AKT/Bcl 2 pat ......"26067553Flow cytometry; MTT assay
hsa-miR-101-3p

retinoblastomacell cycle pathway; Apoptosis pathway"MiR 101 downregulated in retinoblastoma functions ......"24807198
hsa-miR-101-3p

sarcomaApoptosis pathway"Studies have proved that microRNA-101 miR-101 func ......"25480586



Reported cancer prognosis affected by hsa-miR-101-3p

miRNAcancerprognosisreportingPUBMEDfunctional study
hsa-miR-101-3p

bladder cancercell migration"Here we report that the expression of microRNA-101 ......"23618864
hsa-miR-101-3p

bladder cancercell migration"miR 101 suppresses vascular endothelial growth fac ......"25658842Transwell assay; Western blot; Luciferase; Cell Proliferation Assay
hsa-miR-101-3p

breast cancerstaging"The aim of our study was to investigate the functi ......"26036638Luciferase
hsa-miR-101-3p

breast cancerprogression; staging; metastasis; worse prognosis"Whereas miR-101 is involved in the development and ......"26360780
hsa-miR-101-3p

cervical and endocervical cancertumorigenesis; cell migration"Although aberrant miRNA expression has been docume ......"24289600Flow cytometry; Wound Healing Assay
hsa-miR-101-3p

cervical and endocervical cancertumorigenesis; motility"Previously we found that miR-101 is significantly ......"26617722MTT assay; Flow cytometry
hsa-miR-101-3p

colon cancermotility"MicroRNA 101 miR 101 post transcriptionally regula ......"22353936Luciferase
hsa-miR-101-3p

colon cancerpoor survival; malignant trasformation; worse prognosis"Loss of miR 101 expression promotes Wnt/β catenin ......"22930392
hsa-miR-101-3p

colorectal cancerprogression"Downloading from GEO Gene Expression Omnibus datab ......"25755742
hsa-miR-101-3p

colorectal cancerpoor survival"Two miRNAs infrequently expressed in the populatio ......"27517623
hsa-miR-101-3p

esophageal cancermetastasis"miR 101 suppresses tumor proliferation and migrati ......"25400732Flow cytometry; Wound Healing Assay
hsa-miR-101-3p

esophageal cancerprogression; metastasis"Cyclooxygenase 2 a Potential Therapeutic Target Is ......"26556718Flow cytometry; Western blot; Luciferase
hsa-miR-101-3p

gastric cancermetastasis"Downregulation of miR 101 in gastric cancer correl ......"23013439
hsa-miR-101-3p

gastric cancerprogression; tumorigenesis"Expressions of COX 2 PKC α and miR 101 in gastric ......"23644120Western blot
hsa-miR-101-3p

gastric cancertumorigenesis; progression"MiR 101 inhibits cell growth and tumorigenesis of ......"25561270Colony formation
hsa-miR-101-3p

gastric cancercell migration"miR 101 2 miR 125b 2 and miR 451a act as potential ......"26458815Western blot; Colony formation
hsa-miR-101-3p

gastric cancerprogression; worse prognosis"Long non coding RNA XIST regulates gastric cancer ......"27620004
hsa-miR-101-3p

glioblastomaprogression"miR 101 is down regulated in glioblastoma resultin ......"21321380
hsa-miR-101-3p

glioblastomapoor survival"miR 101 acts as a tumor suppressor by targeting Kr ......"25230316Luciferase
hsa-miR-101-3p

head and neck cancermalignant trasformation"A global miRNA profiling was performed on 12 sampl ......"21637912
hsa-miR-101-3p

kidney renal cell cancercell migration"Restoration of miR-101 significantly inhibited cel ......"27487138
hsa-miR-101-3p

liver cancertumorigenesis"miR-101 a significantly down-regulated miRNA was f ......"19155302Luciferase
hsa-miR-101-3p

liver cancerworse prognosis; progression"Ectopic expression of miR-101 significantly inhibi ......"23178713
hsa-miR-101-3p

liver cancerdrug resistance"miR 101 inhibits autophagy and enhances cisplatin ......"23483142
hsa-miR-101-3p

liver cancertumorigenesis; malignant trasformation; worse prognosis"Furthermore miR-101 an important tumor-suppressive ......"24002871
hsa-miR-101-3p

liver cancerprogression"Oncogene polycomb group protein enhancer of zeste ......"24211739Luciferase; Colony formation
hsa-miR-101-3p

liver cancerworse prognosis; tumor size; progression"Based on our prior observations that miRNA-101 miR ......"24260081
hsa-miR-101-3p

liver cancermetastasis; poor survival; tumorigenesis"However the efficacy of miR-101 replacement therap ......"25693145
hsa-miR-101-3p

liver cancerprogression"Single Nucleotide Polymorphisms in miR 149 rs22928 ......"26434859
hsa-miR-101-3p

liver cancertumorigenesis"Reciprocal negative feedback loop between EZH2 and ......"26718325
hsa-miR-101-3p

liver cancermetastasis; cell migration"miRNA miR-101 has been suggested to be associated ......"26870229
hsa-miR-101-3p

lung cancertumorigenesis"miR 101 DNA copy loss is a prominent subtype speci ......"21849855
hsa-miR-101-3p

lung cancertumorigenesis; metastasis"Restoration of miR 101 suppresses lung tumorigenes ......"25210796Luciferase
hsa-miR-101-3p

lung cancerprogression"At the same time microRNA-101 mir-101 was found to ......"25428391
hsa-miR-101-3p

lung cancermetastasis"miR 101 represses lung cancer by inhibiting intera ......"26349988
hsa-miR-101-3p

lung cancerprogression"The deregulation of miR-101 has been implicated in ......"26628987Luciferase
hsa-miR-101-3p

lung squamous cell cancerdrug resistance"In this study we investigate whether miRNA miR-101 ......"21270667Luciferase
hsa-miR-101-3p

lung squamous cell cancerstaging; worse prognosis; poor survival; progression"MiR 101 and Mcl 1 in non small cell lung cancer: e ......"21993632Western blot
hsa-miR-101-3p

lung squamous cell cancerdrug resistance; malignant trasformation"Radiosensitizing effects of ectopic miR 101 on non ......"22014955Western blot
hsa-miR-101-3p

lymphomadifferentiation"MicroRNA profiles were correlated with correspondi ......"21960592
hsa-miR-101-3p

melanomastaging; poor survival"MiR 101 inhibits melanoma cell invasion and prolif ......"23962556
hsa-miR-101-3p

ovarian cancermotility"MicroRNA-101 miR-101 expression is negatively asso ......"21818714Wound Healing Assay
hsa-miR-101-3p

ovarian cancercell migration"MiR 101 suppresses the epithelial to mesenchymal t ......"24677166
hsa-miR-101-3p

ovarian cancerprogression; drug resistance; malignant trasformation; tumorigenesis; staging; differentiation"miR 101 regulates expression of EZH2 and contribut ......"25260883
hsa-miR-101-3p

pancreatic cancertumorigenesis"miR-122 let-7 family and miR-101 are down-regulate ......"22303361
hsa-miR-101-3p

pancreatic cancerstaging; metastasis; poor survival"miR-101 is an outstanding tumor suppressor in vari ......"25968875Western blot; Luciferase
hsa-miR-101-3p

prostate cancermalignant trasformation"The expression of nine selected miRNAs hsa-miR-101 ......"24517338Luciferase
hsa-miR-101-3p

prostate cancerprogression; tumorigenesis"RLIP76 dependent suppression of PI3K/AKT/Bcl 2 pat ......"26067553Flow cytometry; MTT assay
hsa-miR-101-3p

prostate cancermetastasis; progression"Some of the genes that are negatively regulated by ......"27270442
hsa-miR-101-3p

retinoblastomaprogression"MiR 101 downregulated in retinoblastoma functions ......"24807198
hsa-miR-101-3p

sarcomacell migration"miR-101 is downregulated in various types of cance ......"25190211
hsa-miR-101-3p

thyroid cancermetastasis; cell migration"In previous studies the role of miRNA-101 miR-101 ......"25202416Luciferase



Reported gene related to hsa-miR-101-3p

miRNAcancergenereportingPUBMED
hsa-miR-101-3p

bladder cancerEZH2"Methyl jasmonate sensitizes human bladder cancer c ......"24490857
hsa-miR-101-3p

breast cancerEZH2"Main objective of the present study is to investig ......"22094936
hsa-miR-101-3p

esophageal cancerEZH2"miR 101 suppresses tumor proliferation and migrati ......"25400732
hsa-miR-101-3p

gastric cancerEZH2"Long non coding RNA XIST regulates gastric cancer ......"27620004
hsa-miR-101-3p

gastric cancerEZH2"Moreover around 40% of cases showing miR-101 down- ......"22450781
hsa-miR-101-3p

glioblastomaEZH2"miR 101 is down regulated in glioblastoma resultin ......"21321380
hsa-miR-101-3p

liver cancerEZH2"miR-101 in turn inhibits the expression of two sub ......"24002871
hsa-miR-101-3p

liver cancerEZH2"Reporter gene assays revealed that ectopic express ......"26718325
hsa-miR-101-3p

liver cancerEZH2"The aim of our study was to investigate the functi ......"24211739
hsa-miR-101-3p

lung cancerEZH2"The results showed that mir-101 was down-regulated ......"25428391
hsa-miR-101-3p

lung cancerEZH2"Therefore we aimed to ascertain whether or not the ......"22977606
hsa-miR-101-3p

lung squamous cell cancerEZH2"In this study we investigate whether miRNA miR-101 ......"21270667
hsa-miR-101-3p

melanomaEZH2"MiR 101 inhibits melanoma cell invasion and prolif ......"23962556
hsa-miR-101-3p

ovarian cancerEZH2"We explore the role of miR-101 and its interaction ......"21818714
hsa-miR-101-3p

ovarian cancerEZH2"miR 101 regulates expression of EZH2 and contribut ......"25260883
hsa-miR-101-3p

pancreatic cancerEZH2"Mechanistic investigations revealed that reexpress ......"22108826
hsa-miR-101-3p

retinoblastomaEZH2"MiR 101 downregulated in retinoblastoma functions ......"24807198
hsa-miR-101-3p

sarcomaEZH2"MiR-101 is a microRNA involved in a negative feedb ......"26251675
hsa-miR-101-3p

sarcomaEZH2"In the present study we reported that ectopic over ......"25190211
hsa-miR-101-3p

bladder cancerPTGS2"Enforced expression of miR 101 enhances cisplatin ......"25109742
hsa-miR-101-3p

cervical and endocervical cancerPTGS2"The expression of COX-2 in Hela cell was also exam ......"24289600
hsa-miR-101-3p

cervical and endocervical cancerPTGS2"Immunohistochemistry was performed to assess prote ......"26617722
hsa-miR-101-3p

cervical and endocervical cancerPTGS2"Roles of MiR 101 and its target gene Cox 2 in earl ......"24528073
hsa-miR-101-3p

colon cancerPTGS2"MiR 101 downregulation is involved in cyclooxygena ......"19133256
hsa-miR-101-3p

esophageal cancerPTGS2"Luciferase assay revealed that COX-2 was a direct ......"26530100
hsa-miR-101-3p

esophageal cancerPTGS2"Cyclooxygenase 2 a Potential Therapeutic Target Is ......"26556718
hsa-miR-101-3p

gastric cancerPTGS2"Expressions of COX 2 PKC α and miR 101 in gastric ......"23644120
hsa-miR-101-3p

gastric cancerPTGS2"Downregulation of miR 101 in gastric cancer correl ......"23013439
hsa-miR-101-3p

liver cancerPTGS2"MiR-16 and miR-101 levels do not correlate with CO ......"24759835
hsa-miR-101-3p

lung cancerPTGS2"Interestingly cyclooxygenase-2 inhibition by aspir ......"24958470
hsa-miR-101-3p

prostate cancerPTGS2"Enforced expression of miR 101 inhibits prostate c ......"21430074
hsa-miR-101-3p

breast cancerCDH1"The overexpression of miR-101 resulted in downregu ......"26927545
hsa-miR-101-3p

gastric cancerCDH1"Moreover around 40% of cases showing miR-101 down- ......"22450781
hsa-miR-101-3p

lung cancerCDH1"A reduction in the trimethyl H3K27 histone mark wa ......"22977606
hsa-miR-101-3p

ovarian cancerCDH1"Our findings showed that miR-101 represents a redu ......"24677166
hsa-miR-101-3p

breast cancerMCL1"The aim of our study was to investigate the functi ......"26036638
hsa-miR-101-3p

liver cancerMCL1"Moreover silencing of Mcl-1 phenocopied the effect ......"19155302
hsa-miR-101-3p

lung squamous cell cancerMCL1"MiR 101 and Mcl 1 in non small cell lung cancer: e ......"21993632
hsa-miR-101-3p

colorectal cancerRAC1"Mir-101 inhibitors significantly increased the luc ......"25057058
hsa-miR-101-3p

thyroid cancerRAC1"In previous studies the role of miRNA-101 miR-101 ......"25202416
hsa-miR-101-3p

thyroid cancerRAC1"miR 101 inhibits cell proliferation by targeting R ......"24649082
hsa-miR-101-3p

liver cancerCXCL12"Vascular mimicry formation is promoted by paracrin ......"27693460
hsa-miR-101-3p

lung cancerCXCL12"miR 101 represses lung cancer by inhibiting intera ......"26349988
hsa-miR-101-3p

breast cancerDNMT3A"The expressions of miR-101 and DNA methyltransfera ......"26927545
hsa-miR-101-3p

lung cancerDNMT3A"Restoration of miR 101 suppresses lung tumorigenes ......"25210796
hsa-miR-101-3p

lymphomaMTOR"Furthermore inhibition of mTOR which is targeted b ......"20805506
hsa-miR-101-3p

sarcomaMTOR"Meanwhile bioinformatic analysis demonstrated that ......"25480586
hsa-miR-101-3p

liver cancerMYC"In addition co-overexpression of c-Myc and EZH2 in ......"24002871
hsa-miR-101-3p

liver cancerMYC"Furthermore miR-101 significantly suppressed both ......"25762642
hsa-miR-101-3p

gastric cancerSOCS2"MiR 101 inhibits cell growth and tumorigenesis of ......"25561270
hsa-miR-101-3p

ovarian cancerSOCS2"Real time polymerase chain reaction RT-PCR was emp ......"26884939
hsa-miR-101-3p

bladder cancerVEGFC"miR-101 and VEGF-C interference independently enha ......"25658842
hsa-miR-101-3p

liver cancerVEGFC"Vascular endothelial growth factor VEGF-C was furt ......"26870229
hsa-miR-101-3p

breast cancerACKR3"CX chemokine receptor 7 CXCR7 is a direct target o ......"26360780
hsa-miR-101-3p

prostate cancerAR"Since miR-101 is an inhibitor of autophagy and its ......"26473737
hsa-miR-101-3p

lung squamous cell cancerATM"Although ectopic miR-101 efficiently decreased the ......"22014955
hsa-miR-101-3p

head and neck cancerBRIP1"Further functional analyses showed that SNP rs7213 ......"26711789
hsa-miR-101-3p

lung cancerCDKN2A"Finally miR-101 deletions on 9p were exclusive of ......"21849855
hsa-miR-101-3p

esophageal cancerCSE"Taken together our findings revealed a new post-tr ......"26530100
hsa-miR-101-3p

liver cancerEED"miR-101 in turn inhibits the expression of two sub ......"24002871
hsa-miR-101-3p

pancreatic cancerEPCAM"Mechanistic investigations revealed that reexpress ......"22108826
hsa-miR-101-3p

cervical and endocervical cancerFOS"miR 101 inhibits the G1 to S phase transition of c ......"24987920
hsa-miR-101-3p

pancreatic cancerHMGA2"We identified high-mobility group AT-hook 2 HMGA2 ......"25968875
hsa-miR-101-3p

liver cancerIKBKG"MiR 101 functions as a tumor suppressor by directl ......"24189458
hsa-miR-101-3p

breast cancerJAK2"miR 101 promotes breast cancer cell apoptosis by t ......"25059472
hsa-miR-101-3p

glioblastomaKLF6"One direct target of miR-101 the transcription fac ......"25230316
hsa-miR-101-3p

thyroid cancerKRT1"Restoration of miR-101 expression significantly in ......"24649082
hsa-miR-101-3p

lung cancerLIN28B"Lin28B was identified as critical effector target ......"24958470
hsa-miR-101-3p

esophageal cancerMALAT1"Silencing of long noncoding RNA MALAT1 by miR 101 ......"25538231
hsa-miR-101-3p

lung cancerMARK1"A reduction in the trimethyl H3K27 histone mark wa ......"22977606
hsa-miR-101-3p

bladder cancerMET"We found that miR-101 directly targets c-Met via i ......"23618864
hsa-miR-101-3p

pancreatic cancerMIA"MIA PaCa-2 and PANC-1 cells transfected with miR-1 ......"25841339
hsa-miR-101-3p

melanomaMITF"MiR 101 inhibits melanoma cell invasion and prolif ......"23962556
hsa-miR-101-3p

lung cancerMMP2"Moreover the expression of CDH1 and MMP-2 was reve ......"22977606
hsa-miR-101-3p

liver cancerNLK"MiR 101 functions as a tumor suppressor by directl ......"24189458
hsa-miR-101-3p

pancreatic cancerPKM"miR-101 or miR-24-2 over-expressing cells when tre ......"25841339
hsa-miR-101-3p

lung squamous cell cancerPRKDC"Although ectopic miR-101 efficiently decreased the ......"22014955
hsa-miR-101-3p

colon cancerPTGER4"MicroRNA 101 miR 101 post transcriptionally regula ......"22353936
hsa-miR-101-3p

liver cancerRAB5A"Downregulation of miR 101 3p by hepatitis B virus ......"24788845
hsa-miR-101-3p

prostate cancerRALA"To verify the mechanisms we identified a novel miR ......"26067553
hsa-miR-101-3p

prostate cancerRALBP1"RLIP76 dependent suppression of PI3K/AKT/Bcl 2 pat ......"26067553
hsa-miR-101-3p

liver cancerRAP1B"Functional analysis of miR 101 3p and Rap1b involv ......"24697700
hsa-miR-101-3p

lung cancerRUNX1"Mechanistically we indicated that miR-101 inversel ......"26628987
hsa-miR-101-3p

liver cancerSNHG6"SNHG6 may act as a competing endogenous RNA effect ......"27702662
hsa-miR-101-3p

colorectal cancerSNORD44"MiR-101 was hardly expressed in the tumor samples ......"23121918
hsa-miR-101-3p

liver cancerSOX9"Ectopic expression of miR-101 significantly inhibi ......"23178713
hsa-miR-101-3p

colorectal cancerSPHK1"In the current study we demonstrate that microRNA- ......"26071354
hsa-miR-101-3p

breast cancerSTAT3"STAT3 signaling downstream of CXCR7 is involved in ......"26360780
hsa-miR-101-3p

prostate cancerSUB1"Thus our study suggests that miR-101 loss results ......"27270442
hsa-miR-101-3p

prostate cancerTNMD"We first demonstrated that miR-101 treatment promo ......"26067553
hsa-miR-101-3p

liver cancerTRIB3"SNHG6 may act as a competing endogenous RNA effect ......"27702662
hsa-miR-101-3p

gastric cancerXIST"Long non coding RNA XIST regulates gastric cancer ......"27620004
hsa-miR-101-3p

ovarian cancerZEB1"MiR 101 suppresses the epithelial to mesenchymal t ......"24677166
hsa-miR-101-3p

ovarian cancerZEB2"MiR 101 suppresses the epithelial to mesenchymal t ......"24677166



Expression profile in cancer corhorts:




Putative target regulations

miRNAGeneCancerInteractionCorrelation beta
hsa-miR-101-3p
ATP5B
9 cancers: BLCA; BRCA; COAD; KIRC; LUAD; LUSC; PRAD; THCA; STAD
miRNAWalker2 validate; miRTarBase
TCGA BLCA -0.082; TCGA BRCA -0.133; TCGA COAD -0.144; TCGA KIRC -0.252; TCGA LUAD -0.081; TCGA LUSC -0.169; TCGA PRAD -0.074; TCGA THCA -0.155; TCGA STAD -0.165
hsa-miR-101-3p
BIRC5
15 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; UCEC
miRNAWalker2 validate
TCGA BLCA -0.216; TCGA BRCA -0.558; TCGA CESC -0.197; TCGA ESCA -0.517; TCGA HNSC -0.431; TCGA KIRP -0.601; TCGA LGG -0.564; TCGA LIHC -1.327; TCGA LUAD -0.312; TCGA LUSC -1.143; TCGA OV -0.31; TCGA PAAD -0.581; TCGA PRAD -0.383; TCGA SARC -0.284; TCGA UCEC -0.595
hsa-miR-101-3p
FBN2
11 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LIHC; LUSC; OV; SARC; THCA
miRNAWalker2 validate; MirTarget; miRNATAP
TCGA BLCA -0.352; TCGA BRCA -0.449; TCGA CESC -0.596; TCGA HNSC -0.584; TCGA KIRC -0.83; TCGA LGG -0.224; TCGA LIHC -0.276; TCGA LUSC -0.735; TCGA OV -0.552; TCGA SARC -0.359; TCGA THCA -0.279
hsa-miR-101-3p
FZD6
10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LIHC; LUSC; PAAD; SARC; STAD
miRNAWalker2 validate; MirTarget
TCGA BLCA -0.15; TCGA BRCA -0.184; TCGA ESCA -0.537; TCGA HNSC -0.152; TCGA KIRC -0.493; TCGA LIHC -0.313; TCGA LUSC -0.266; TCGA PAAD -0.327; TCGA SARC -0.677; TCGA STAD -0.187
hsa-miR-101-3p
GNB1
10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; OV; THCA; STAD; UCEC
miRNAWalker2 validate; MirTarget; miRNATAP
TCGA BLCA -0.136; TCGA BRCA -0.075; TCGA CESC -0.088; TCGA ESCA -0.113; TCGA HNSC -0.15; TCGA LIHC -0.066; TCGA OV -0.066; TCGA THCA -0.107; TCGA STAD -0.113; TCGA UCEC -0.088
hsa-miR-101-3p
KIF2C
16 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.282; TCGA BRCA -0.453; TCGA CESC -0.136; TCGA ESCA -0.36; TCGA HNSC -0.276; TCGA KIRP -0.297; TCGA LGG -0.323; TCGA LIHC -1.297; TCGA LUAD -0.291; TCGA LUSC -1.022; TCGA OV -0.186; TCGA PAAD -0.384; TCGA PRAD -0.262; TCGA SARC -0.292; TCGA STAD -0.342; TCGA UCEC -0.416
hsa-miR-101-3p
LBR
11 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LGG; LIHC; LUSC; OV; SARC; STAD
miRNAWalker2 validate
TCGA BLCA -0.197; TCGA BRCA -0.163; TCGA ESCA -0.183; TCGA KIRC -0.135; TCGA KIRP -0.154; TCGA LGG -0.14; TCGA LIHC -0.156; TCGA LUSC -0.141; TCGA OV -0.212; TCGA SARC -0.186; TCGA STAD -0.252
hsa-miR-101-3p
LMNB1
10 cancers: BLCA; BRCA; LGG; LIHC; LUAD; LUSC; OV; SARC; THCA; UCEC
miRNAWalker2 validate; MirTarget; miRNATAP
TCGA BLCA -0.144; TCGA BRCA -0.28; TCGA LGG -0.321; TCGA LIHC -0.363; TCGA LUAD -0.139; TCGA LUSC -0.443; TCGA OV -0.156; TCGA SARC -0.295; TCGA THCA -0.128; TCGA UCEC -0.337
hsa-miR-101-3p
MAP2K1
9 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUSC; SARC; THCA; STAD
miRNAWalker2 validate
TCGA BLCA -0.179; TCGA BRCA -0.158; TCGA CESC -0.21; TCGA COAD -0.185; TCGA ESCA -0.211; TCGA LUSC -0.078; TCGA SARC -0.143; TCGA THCA -0.133; TCGA STAD -0.118
hsa-miR-101-3p
PPP4R1
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; OV; PAAD; SARC; THCA; STAD
miRNAWalker2 validate
TCGA BLCA -0.156; TCGA BRCA -0.073; TCGA CESC -0.13; TCGA COAD -0.165; TCGA ESCA -0.288; TCGA HNSC -0.18; TCGA LGG -0.075; TCGA LIHC -0.165; TCGA OV -0.096; TCGA PAAD -0.284; TCGA SARC -0.081; TCGA THCA -0.083; TCGA STAD -0.124
hsa-miR-101-3p
PTGS2
9 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LUAD; PAAD; SARC; STAD
miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP
TCGA BLCA -0.546; TCGA COAD -0.466; TCGA ESCA -0.694; TCGA HNSC -0.296; TCGA KIRC -0.957; TCGA LUAD -0.25; TCGA PAAD -0.656; TCGA SARC -0.568; TCGA STAD -0.495
hsa-miR-101-3p
RTN4
9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; PAAD; PRAD
miRNAWalker2 validate
TCGA BLCA -0.166; TCGA BRCA -0.094; TCGA COAD -0.12; TCGA ESCA -0.367; TCGA HNSC -0.186; TCGA KIRC -0.245; TCGA LUAD -0.076; TCGA PAAD -0.216; TCGA PRAD -0.097
hsa-miR-101-3p
STAMBP
9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUSC; PAAD
miRNAWalker2 validate; MirTarget
TCGA BLCA -0.089; TCGA BRCA -0.158; TCGA CESC -0.081; TCGA ESCA -0.1; TCGA HNSC -0.102; TCGA KIRC -0.132; TCGA LIHC -0.071; TCGA LUSC -0.235; TCGA PAAD -0.126
hsa-miR-101-3p
TGFBR1
10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; OV; STAD
miRNAWalker2 validate; miRNATAP
TCGA BLCA -0.356; TCGA BRCA -0.226; TCGA CESC -0.258; TCGA COAD -0.173; TCGA ESCA -0.334; TCGA HNSC -0.137; TCGA KIRC -0.167; TCGA LGG -0.069; TCGA OV -0.077; TCGA STAD -0.159
hsa-miR-101-3p
TMTC3
12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.151; TCGA BRCA -0.194; TCGA COAD -0.225; TCGA ESCA -0.553; TCGA HNSC -0.08; TCGA LUAD -0.084; TCGA LUSC -0.33; TCGA OV -0.153; TCGA SARC -0.135; TCGA THCA -0.103; TCGA STAD -0.144; TCGA UCEC -0.066
hsa-miR-101-3p
VAPA
9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; PAAD; PRAD; STAD
miRNAWalker2 validate
TCGA BLCA -0.147; TCGA CESC -0.068; TCGA COAD -0.191; TCGA ESCA -0.136; TCGA HNSC -0.067; TCGA KIRC -0.072; TCGA PAAD -0.118; TCGA PRAD -0.07; TCGA STAD -0.108
hsa-miR-101-3p
VEZT
10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; OV; SARC
miRNAWalker2 validate
TCGA BLCA -0.138; TCGA BRCA -0.12; TCGA CESC -0.075; TCGA COAD -0.22; TCGA ESCA -0.334; TCGA HNSC -0.082; TCGA KIRC -0.076; TCGA KIRP -0.089; TCGA OV -0.07; TCGA SARC -0.162
hsa-miR-101-3p
CDKN1A
11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; OV; PAAD; PRAD; THCA; UCEC
MirTarget
TCGA BLCA -0.196; TCGA BRCA -0.125; TCGA COAD -0.404; TCGA ESCA -0.448; TCGA HNSC -0.259; TCGA LUAD -0.077; TCGA OV -0.185; TCGA PAAD -0.313; TCGA PRAD -0.32; TCGA THCA -0.481; TCGA UCEC -0.322
hsa-miR-101-3p
UBE2F
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PRAD; STAD; UCEC
MirTarget
TCGA BLCA -0.221; TCGA BRCA -0.17; TCGA CESC -0.115; TCGA COAD -0.094; TCGA ESCA -0.135; TCGA HNSC -0.226; TCGA KIRC -0.19; TCGA LUAD -0.065; TCGA LUSC -0.147; TCGA OV -0.1; TCGA PRAD -0.125; TCGA STAD -0.11; TCGA UCEC -0.131
hsa-miR-101-3p
DIP2B
9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; THCA; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.247; TCGA BRCA -0.131; TCGA CESC -0.131; TCGA ESCA -0.396; TCGA HNSC -0.1; TCGA LUAD -0.081; TCGA LUSC -0.281; TCGA THCA -0.147; TCGA UCEC -0.07
hsa-miR-101-3p
ZFAND3
11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LGG; LIHC; OV; THCA; STAD
MirTarget; miRNATAP
TCGA BLCA -0.095; TCGA BRCA -0.067; TCGA CESC -0.126; TCGA COAD -0.075; TCGA HNSC -0.05; TCGA KIRC -0.095; TCGA LGG -0.073; TCGA LIHC -0.054; TCGA OV -0.058; TCGA THCA -0.1; TCGA STAD -0.15
hsa-miR-101-3p
TLK2
10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; STAD
MirTarget
TCGA BLCA -0.054; TCGA BRCA -0.136; TCGA ESCA -0.198; TCGA HNSC -0.063; TCGA KIRC -0.061; TCGA KIRP -0.081; TCGA LIHC -0.093; TCGA LUAD -0.057; TCGA LUSC -0.072; TCGA STAD -0.122
hsa-miR-101-3p
KPNB1
11 cancers: BLCA; BRCA; CESC; ESCA; LIHC; LUAD; LUSC; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.162; TCGA BRCA -0.094; TCGA CESC -0.13; TCGA ESCA -0.161; TCGA LIHC -0.14; TCGA LUAD -0.079; TCGA LUSC -0.159; TCGA SARC -0.17; TCGA THCA -0.109; TCGA STAD -0.157; TCGA UCEC -0.075
hsa-miR-101-3p
POMP
11 cancers: BLCA; BRCA; CESC; HNSC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC
MirTarget
TCGA BLCA -0.177; TCGA BRCA -0.219; TCGA CESC -0.089; TCGA HNSC -0.158; TCGA LUAD -0.067; TCGA LUSC -0.094; TCGA OV -0.183; TCGA PAAD -0.173; TCGA PRAD -0.157; TCGA STAD -0.144; TCGA UCEC -0.137
hsa-miR-101-3p
TIMM17A
14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.184; TCGA BRCA -0.226; TCGA CESC -0.062; TCGA COAD -0.147; TCGA HNSC -0.161; TCGA KIRC -0.083; TCGA LUSC -0.187; TCGA OV -0.079; TCGA PAAD -0.183; TCGA PRAD -0.169; TCGA SARC -0.129; TCGA THCA -0.078; TCGA STAD -0.261; TCGA UCEC -0.1
hsa-miR-101-3p
XPO5
12 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; THCA; STAD
MirTarget
TCGA BLCA -0.157; TCGA BRCA -0.202; TCGA CESC -0.174; TCGA HNSC -0.14; TCGA KIRC -0.168; TCGA KIRP -0.139; TCGA LGG -0.102; TCGA LIHC -0.277; TCGA LUAD -0.073; TCGA LUSC -0.364; TCGA THCA -0.092; TCGA STAD -0.348
hsa-miR-101-3p
DENR
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; STAD
MirTarget
TCGA BLCA -0.104; TCGA BRCA -0.145; TCGA CESC -0.093; TCGA COAD -0.092; TCGA ESCA -0.242; TCGA HNSC -0.105; TCGA KIRC -0.159; TCGA KIRP -0.148; TCGA LIHC -0.205; TCGA LUAD -0.074; TCGA LUSC -0.253; TCGA PRAD -0.056; TCGA STAD -0.237
hsa-miR-101-3p
DNM1L
11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; STAD
MirTarget
TCGA BLCA -0.086; TCGA BRCA -0.144; TCGA CESC -0.079; TCGA COAD -0.124; TCGA ESCA -0.23; TCGA HNSC -0.084; TCGA KIRC -0.249; TCGA LIHC -0.2; TCGA LUAD -0.085; TCGA LUSC -0.196; TCGA STAD -0.189
hsa-miR-101-3p
PRR11
12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; OV; SARC; THCA; UCEC
MirTarget
TCGA BLCA -0.617; TCGA BRCA -0.658; TCGA CESC -0.493; TCGA COAD -0.232; TCGA ESCA -0.591; TCGA LIHC -0.678; TCGA LUAD -0.259; TCGA LUSC -0.627; TCGA OV -0.197; TCGA SARC -0.665; TCGA THCA -0.353; TCGA UCEC -0.351
hsa-miR-101-3p
MTMR2
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA
MirTarget; miRNATAP
TCGA BLCA -0.211; TCGA BRCA -0.199; TCGA CESC -0.15; TCGA COAD -0.119; TCGA ESCA -0.155; TCGA HNSC -0.124; TCGA LIHC -0.396; TCGA LUAD -0.098; TCGA LUSC -0.121; TCGA OV -0.085; TCGA PAAD -0.144; TCGA SARC -0.21; TCGA THCA -0.094
hsa-miR-101-3p
UGGT1
12 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LIHC; LUAD; LUSC; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.179; TCGA BRCA -0.185; TCGA CESC -0.149; TCGA ESCA -0.158; TCGA KIRC -0.199; TCGA LIHC -0.122; TCGA LUAD -0.079; TCGA LUSC -0.132; TCGA SARC -0.121; TCGA THCA -0.217; TCGA STAD -0.112; TCGA UCEC -0.179
hsa-miR-101-3p
KIF5B
10 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LIHC; LUAD; SARC; THCA; STAD
MirTarget; miRNATAP
TCGA BLCA -0.173; TCGA BRCA -0.152; TCGA CESC -0.103; TCGA ESCA -0.222; TCGA KIRC -0.15; TCGA LIHC -0.134; TCGA LUAD -0.051; TCGA SARC -0.133; TCGA THCA -0.099; TCGA STAD -0.191
hsa-miR-101-3p
ENY2
10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUSC; PAAD; STAD; UCEC
MirTarget
TCGA BLCA -0.111; TCGA BRCA -0.183; TCGA COAD -0.16; TCGA ESCA -0.213; TCGA HNSC -0.224; TCGA LIHC -0.138; TCGA LUSC -0.212; TCGA PAAD -0.126; TCGA STAD -0.153; TCGA UCEC -0.117
hsa-miR-101-3p
NOTCH1
9 cancers: BLCA; ESCA; LGG; LIHC; OV; PAAD; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.145; TCGA ESCA -0.41; TCGA LGG -0.187; TCGA LIHC -0.126; TCGA OV -0.147; TCGA PAAD -0.169; TCGA THCA -0.188; TCGA STAD -0.201; TCGA UCEC -0.116
hsa-miR-101-3p
SRPK2
9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUSC; THCA
MirTarget; miRNATAP
TCGA BLCA -0.075; TCGA BRCA -0.101; TCGA CESC -0.177; TCGA ESCA -0.348; TCGA HNSC -0.168; TCGA KIRC -0.173; TCGA LIHC -0.148; TCGA LUSC -0.167; TCGA THCA -0.124
hsa-miR-101-3p
ASAP1
9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUAD; SARC; THCA
MirTarget; miRNATAP
TCGA BLCA -0.308; TCGA BRCA -0.154; TCGA CESC -0.122; TCGA ESCA -0.301; TCGA HNSC -0.092; TCGA LIHC -0.416; TCGA LUAD -0.137; TCGA SARC -0.187; TCGA THCA -0.22
hsa-miR-101-3p
HTRA3
10 cancers: BLCA; BRCA; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; THCA
MirTarget; miRNATAP
TCGA BLCA -1.146; TCGA BRCA -0.165; TCGA ESCA -0.457; TCGA HNSC -0.53; TCGA LIHC -0.673; TCGA LUAD -0.186; TCGA LUSC -0.229; TCGA OV -0.315; TCGA PAAD -0.5; TCGA THCA -0.227
hsa-miR-101-3p
KIF2A
12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LIHC; LUSC; OV; SARC; THCA; UCEC
MirTarget
TCGA BLCA -0.239; TCGA BRCA -0.117; TCGA CESC -0.098; TCGA COAD -0.138; TCGA ESCA -0.139; TCGA KIRC -0.351; TCGA LIHC -0.29; TCGA LUSC -0.072; TCGA OV -0.07; TCGA SARC -0.131; TCGA THCA -0.152; TCGA UCEC -0.095
hsa-miR-101-3p
ASCC3
9 cancers: BLCA; BRCA; CESC; ESCA; LGG; LUSC; SARC; THCA; UCEC
MirTarget
TCGA BLCA -0.218; TCGA BRCA -0.206; TCGA CESC -0.146; TCGA ESCA -0.187; TCGA LGG -0.052; TCGA LUSC -0.101; TCGA SARC -0.192; TCGA THCA -0.275; TCGA UCEC -0.09
hsa-miR-101-3p
UBE2A
12 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LIHC; LUSC; OV; SARC; THCA; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.185; TCGA BRCA -0.212; TCGA ESCA -0.267; TCGA HNSC -0.078; TCGA KIRC -0.155; TCGA LIHC -0.184; TCGA LUSC -0.112; TCGA OV -0.076; TCGA SARC -0.104; TCGA THCA -0.084; TCGA STAD -0.165; TCGA UCEC -0.073
hsa-miR-101-3p
NAV1
11 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; SARC; UCEC
MirTarget
TCGA BLCA -0.428; TCGA BRCA -0.199; TCGA ESCA -0.61; TCGA HNSC -0.3; TCGA LGG -0.081; TCGA LIHC -0.139; TCGA LUAD -0.171; TCGA LUSC -0.296; TCGA OV -0.129; TCGA SARC -0.164; TCGA UCEC -0.206
hsa-miR-101-3p
DCUN1D1
9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LUSC; OV; SARC; STAD
MirTarget
TCGA BLCA -0.113; TCGA BRCA -0.195; TCGA COAD -0.109; TCGA ESCA -0.284; TCGA KIRC -0.416; TCGA LUSC -0.228; TCGA OV -0.115; TCGA SARC -0.136; TCGA STAD -0.149
hsa-miR-101-3p
CHAC2
9 cancers: BLCA; BRCA; CESC; COAD; KIRC; LGG; LUSC; OV; SARC
MirTarget
TCGA BLCA -0.266; TCGA BRCA -0.231; TCGA CESC -0.183; TCGA COAD -0.241; TCGA KIRC -0.406; TCGA LGG -0.12; TCGA LUSC -0.417; TCGA OV -0.213; TCGA SARC -0.156
hsa-miR-101-3p
B3GALNT2
13 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.218; TCGA BRCA -0.172; TCGA CESC -0.104; TCGA ESCA -0.24; TCGA KIRC -0.169; TCGA LIHC -0.245; TCGA LUAD -0.072; TCGA LUSC -0.292; TCGA PAAD -0.192; TCGA SARC -0.219; TCGA THCA -0.112; TCGA STAD -0.246; TCGA UCEC -0.121
hsa-miR-101-3p
ARNTL2
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; OV; PAAD; SARC; THCA; UCEC
MirTarget
TCGA BLCA -0.729; TCGA BRCA -0.377; TCGA CESC -0.182; TCGA COAD -0.262; TCGA ESCA -0.526; TCGA HNSC -0.155; TCGA LIHC -0.416; TCGA LUSC -0.792; TCGA OV -0.298; TCGA PAAD -0.416; TCGA SARC -0.614; TCGA THCA -0.605; TCGA UCEC -0.191
hsa-miR-101-3p
RAB1A
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; OV; PAAD; PRAD; STAD
MirTarget; miRNATAP
TCGA BLCA -0.103; TCGA BRCA -0.205; TCGA CESC -0.107; TCGA COAD -0.117; TCGA ESCA -0.111; TCGA HNSC -0.109; TCGA KIRC -0.137; TCGA LIHC -0.067; TCGA LUSC -0.129; TCGA OV -0.056; TCGA PAAD -0.116; TCGA PRAD -0.054; TCGA STAD -0.085
hsa-miR-101-3p
PANK3
10 cancers: BLCA; BRCA; CESC; COAD; KIRC; LUSC; OV; SARC; THCA; UCEC
MirTarget
TCGA BLCA -0.153; TCGA BRCA -0.102; TCGA CESC -0.2; TCGA COAD -0.219; TCGA KIRC -0.239; TCGA LUSC -0.118; TCGA OV -0.17; TCGA SARC -0.177; TCGA THCA -0.189; TCGA UCEC -0.116
hsa-miR-101-3p
RBBP7
10 cancers: BLCA; BRCA; KIRC; LGG; LIHC; LUSC; OV; SARC; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.084; TCGA BRCA -0.119; TCGA KIRC -0.145; TCGA LGG -0.066; TCGA LIHC -0.171; TCGA LUSC -0.172; TCGA OV -0.082; TCGA SARC -0.155; TCGA STAD -0.171; TCGA UCEC -0.155
hsa-miR-101-3p
CDYL
11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; THCA; STAD
MirTarget; miRNATAP
TCGA BLCA -0.121; TCGA BRCA -0.136; TCGA CESC -0.111; TCGA ESCA -0.233; TCGA HNSC -0.076; TCGA KIRC -0.088; TCGA LGG -0.084; TCGA LIHC -0.163; TCGA LUSC -0.185; TCGA THCA -0.058; TCGA STAD -0.157
hsa-miR-101-3p
TMEM167A
10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; OV; THCA
MirTarget
TCGA BLCA -0.093; TCGA BRCA -0.187; TCGA CESC -0.091; TCGA COAD -0.168; TCGA ESCA -0.142; TCGA KIRC -0.097; TCGA KIRP -0.078; TCGA LIHC -0.057; TCGA OV -0.086; TCGA THCA -0.112
hsa-miR-101-3p
EXOC5
9 cancers: BLCA; BRCA; CESC; COAD; ESCA; OV; SARC; THCA; STAD
MirTarget; miRNATAP
TCGA BLCA -0.258; TCGA BRCA -0.184; TCGA CESC -0.155; TCGA COAD -0.085; TCGA ESCA -0.373; TCGA OV -0.069; TCGA SARC -0.156; TCGA THCA -0.085; TCGA STAD -0.152
hsa-miR-101-3p
RRM1
13 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LGG; LIHC; LUSC; PAAD; PRAD; SARC; THCA; STAD
MirTarget; miRNATAP
TCGA BLCA -0.333; TCGA BRCA -0.134; TCGA COAD -0.105; TCGA ESCA -0.248; TCGA KIRC -0.098; TCGA LGG -0.091; TCGA LIHC -0.14; TCGA LUSC -0.32; TCGA PAAD -0.105; TCGA PRAD -0.067; TCGA SARC -0.211; TCGA THCA -0.082; TCGA STAD -0.201
hsa-miR-101-3p
RANBP1
15 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC
MirTarget
TCGA BLCA -0.102; TCGA BRCA -0.134; TCGA ESCA -0.199; TCGA HNSC -0.268; TCGA KIRC -0.067; TCGA KIRP -0.078; TCGA LGG -0.122; TCGA LIHC -0.081; TCGA LUAD -0.103; TCGA LUSC -0.439; TCGA OV -0.17; TCGA PAAD -0.202; TCGA PRAD -0.134; TCGA STAD -0.161; TCGA UCEC -0.115
hsa-miR-101-3p
DCBLD2
9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; PAAD; SARC; THCA
MirTarget; miRNATAP
TCGA BLCA -0.633; TCGA BRCA -0.091; TCGA CESC -0.158; TCGA HNSC -0.244; TCGA KIRC -0.641; TCGA KIRP -0.329; TCGA PAAD -0.626; TCGA SARC -0.291; TCGA THCA -0.237
hsa-miR-101-3p
JMJD6
11 cancers: BLCA; BRCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD
mirMAP
TCGA BLCA -0.118; TCGA BRCA -0.107; TCGA HNSC -0.123; TCGA KIRP -0.151; TCGA LIHC -0.237; TCGA LUAD -0.105; TCGA LUSC -0.099; TCGA PAAD -0.129; TCGA PRAD -0.085; TCGA SARC -0.13; TCGA STAD -0.163
hsa-miR-101-3p
TLL2
9 cancers: BLCA; BRCA; KIRC; KIRP; LUAD; LUSC; OV; PAAD; THCA
mirMAP
TCGA BLCA -0.315; TCGA BRCA -0.372; TCGA KIRC -1.087; TCGA KIRP -0.69; TCGA LUAD -0.181; TCGA LUSC -0.772; TCGA OV -0.302; TCGA PAAD -0.323; TCGA THCA -0.679
hsa-miR-101-3p
CDK6
9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; THCA
mirMAP
TCGA BLCA -0.728; TCGA CESC -0.422; TCGA ESCA -0.391; TCGA HNSC -0.33; TCGA KIRC -0.23; TCGA LGG -0.214; TCGA LUAD -0.104; TCGA LUSC -0.3; TCGA THCA -0.249
hsa-miR-101-3p
CPA4
11 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; SARC; UCEC
mirMAP
TCGA BLCA -1.311; TCGA BRCA -0.278; TCGA ESCA -1.421; TCGA HNSC -0.662; TCGA KIRC -1.112; TCGA KIRP -0.576; TCGA LIHC -0.448; TCGA LUAD -0.312; TCGA LUSC -1.117; TCGA SARC -0.721; TCGA UCEC -0.559
hsa-miR-101-3p
G3BP1
9 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUSC; THCA; STAD
mirMAP
TCGA BLCA -0.182; TCGA BRCA -0.138; TCGA CESC -0.143; TCGA COAD -0.117; TCGA ESCA -0.208; TCGA KIRC -0.111; TCGA LUSC -0.153; TCGA THCA -0.096; TCGA STAD -0.177
hsa-miR-101-3p
PGAM1
14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC
mirMAP
TCGA BLCA -0.278; TCGA BRCA -0.205; TCGA CESC -0.219; TCGA COAD -0.338; TCGA ESCA -0.382; TCGA HNSC -0.236; TCGA LUAD -0.083; TCGA LUSC -0.331; TCGA PAAD -0.251; TCGA PRAD -0.157; TCGA SARC -0.096; TCGA THCA -0.197; TCGA STAD -0.205; TCGA UCEC -0.225
hsa-miR-101-3p
ATP2A2
12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; SARC; THCA; STAD; UCEC
mirMAP
TCGA BLCA -0.252; TCGA BRCA -0.185; TCGA CESC -0.154; TCGA COAD -0.131; TCGA ESCA -0.257; TCGA LIHC -0.099; TCGA LUAD -0.093; TCGA LUSC -0.257; TCGA SARC -0.274; TCGA THCA -0.199; TCGA STAD -0.252; TCGA UCEC -0.086
hsa-miR-101-3p
PGAM4
12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; SARC; THCA; UCEC
mirMAP
TCGA BLCA -0.333; TCGA BRCA -0.208; TCGA CESC -0.273; TCGA COAD -0.373; TCGA ESCA -0.354; TCGA HNSC -0.137; TCGA LUSC -0.263; TCGA PAAD -0.187; TCGA PRAD -0.134; TCGA SARC -0.24; TCGA THCA -0.265; TCGA UCEC -0.827
hsa-miR-101-3p
PURB
10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUSC; SARC; THCA; STAD
miRNATAP
TCGA BLCA -0.1; TCGA BRCA -0.113; TCGA CESC -0.084; TCGA ESCA -0.224; TCGA HNSC -0.058; TCGA LIHC -0.065; TCGA LUSC -0.159; TCGA SARC -0.099; TCGA THCA -0.059; TCGA STAD -0.144
hsa-miR-101-3p
STC1
10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LIHC; LUAD; LUSC; SARC; UCEC
miRNATAP
TCGA BLCA -0.208; TCGA BRCA -0.184; TCGA CESC -0.512; TCGA COAD -0.26; TCGA HNSC -0.172; TCGA LIHC -0.229; TCGA LUAD -0.288; TCGA LUSC -0.228; TCGA SARC -0.245; TCGA UCEC -0.398
hsa-miR-101-3p
NACC2
9 cancers: BLCA; CESC; COAD; HNSC; LUAD; PAAD; SARC; THCA; STAD
miRNATAP
TCGA BLCA -0.517; TCGA CESC -0.29; TCGA COAD -0.269; TCGA HNSC -0.111; TCGA LUAD -0.12; TCGA PAAD -0.363; TCGA SARC -0.339; TCGA THCA -0.243; TCGA STAD -0.28
hsa-miR-101-3p
ZNF367
11 cancers: BLCA; BRCA; ESCA; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC
miRNATAP
TCGA BLCA -0.236; TCGA BRCA -0.232; TCGA ESCA -0.302; TCGA LGG -0.165; TCGA LUAD -0.148; TCGA LUSC -0.369; TCGA PRAD -0.193; TCGA SARC -0.221; TCGA THCA -0.169; TCGA STAD -0.273; TCGA UCEC -0.148
hsa-miR-101-3p
STRN3
9 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; THCA; STAD
miRNATAP
TCGA BLCA -0.206; TCGA BRCA -0.128; TCGA CESC -0.12; TCGA COAD -0.178; TCGA ESCA -0.385; TCGA HNSC -0.119; TCGA LUSC -0.121; TCGA THCA -0.053; TCGA STAD -0.154
hsa-miR-101-3p
EIF4G2
10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; OV; SARC; THCA; STAD
miRNATAP
TCGA BLCA -0.122; TCGA BRCA -0.166; TCGA CESC -0.118; TCGA COAD -0.118; TCGA ESCA -0.174; TCGA KIRC -0.085; TCGA OV -0.069; TCGA SARC -0.164; TCGA THCA -0.105; TCGA STAD -0.103
hsa-miR-101-3p
FAM199X
10 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LIHC; LUSC; THCA; STAD; UCEC
miRNATAP
TCGA BLCA -0.128; TCGA BRCA -0.151; TCGA CESC -0.091; TCGA ESCA -0.161; TCGA KIRC -0.331; TCGA LIHC -0.091; TCGA LUSC -0.185; TCGA THCA -0.191; TCGA STAD -0.176; TCGA UCEC -0.121
hsa-miR-101-3p
NID2
10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; SARC; THCA; STAD
miRNATAP
TCGA BLCA -0.644; TCGA BRCA -0.357; TCGA CESC -0.213; TCGA ESCA -0.604; TCGA HNSC -0.387; TCGA LGG -0.14; TCGA LUAD -0.197; TCGA SARC -0.401; TCGA THCA -0.143; TCGA STAD -0.438
hsa-miR-101-3p
PHLDA1
10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUSC; OV; PAAD; UCEC
miRNATAP
TCGA BLCA -0.348; TCGA CESC -0.318; TCGA COAD -0.46; TCGA ESCA -0.334; TCGA HNSC -0.151; TCGA LGG -0.216; TCGA LUSC -0.283; TCGA OV -0.195; TCGA PAAD -0.372; TCGA UCEC -0.263
hsa-miR-101-3p
MAP7D1
9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; PAAD; THCA
miRNATAP
TCGA BLCA -0.383; TCGA CESC -0.125; TCGA COAD -0.112; TCGA ESCA -0.298; TCGA HNSC -0.277; TCGA LIHC -0.262; TCGA LUAD -0.07; TCGA PAAD -0.258; TCGA THCA -0.071
hsa-miR-101-3p
TNRC18
9 cancers: BLCA; CESC; ESCA; HNSC; LGG; LIHC; LUSC; PAAD; STAD
miRNATAP
TCGA BLCA -0.066; TCGA CESC -0.2; TCGA ESCA -0.187; TCGA HNSC -0.058; TCGA LGG -0.127; TCGA LIHC -0.152; TCGA LUSC -0.166; TCGA PAAD -0.377; TCGA STAD -0.199
hsa-miR-101-3p
KPNA3
9 cancers: BLCA; BRCA; CESC; ESCA; KIRC; OV; PRAD; THCA; STAD
miRNATAP
TCGA BLCA -0.382; TCGA BRCA -0.197; TCGA CESC -0.161; TCGA ESCA -0.229; TCGA KIRC -0.108; TCGA OV -0.161; TCGA PRAD -0.095; TCGA THCA -0.09; TCGA STAD -0.194
hsa-miR-101-3p
SLC25A3
10 cancers: BLCA; BRCA; CESC; COAD; KIRC; LGG; LIHC; LUAD; LUSC; PRAD
miRNATAP
TCGA BLCA -0.088; TCGA BRCA -0.105; TCGA CESC -0.065; TCGA COAD -0.17; TCGA KIRC -0.176; TCGA LGG -0.062; TCGA LIHC -0.105; TCGA LUAD -0.059; TCGA LUSC -0.085; TCGA PRAD -0.098
hsa-miR-101-3p
TOP1
10 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LGG; OV; THCA; STAD; UCEC
miRNATAP
TCGA BLCA -0.075; TCGA BRCA -0.164; TCGA CESC -0.133; TCGA ESCA -0.185; TCGA KIRC -0.115; TCGA LGG -0.052; TCGA OV -0.055; TCGA THCA -0.125; TCGA STAD -0.143; TCGA UCEC -0.074
hsa-miR-101-3p
BZW1
15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; UCEC
miRNATAP
TCGA BLCA -0.178; TCGA BRCA -0.174; TCGA CESC -0.231; TCGA COAD -0.193; TCGA ESCA -0.262; TCGA HNSC -0.127; TCGA KIRC -0.152; TCGA KIRP -0.096; TCGA LUAD -0.079; TCGA LUSC -0.168; TCGA OV -0.164; TCGA PAAD -0.179; TCGA PRAD -0.126; TCGA THCA -0.08; TCGA UCEC -0.085
hsa-miR-101-3p
ZNF469
11 cancers: BLCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD
miRNATAP
TCGA BLCA -0.77; TCGA CESC -0.246; TCGA ESCA -0.891; TCGA HNSC -0.388; TCGA LIHC -0.349; TCGA LUAD -0.105; TCGA LUSC -0.294; TCGA PAAD -0.619; TCGA SARC -0.315; TCGA THCA -0.419; TCGA STAD -0.454
hsa-miR-101-3p
VCAN
11 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; SARC; THCA; UCEC
miRNATAP
TCGA BLCA -0.844; TCGA BRCA -0.378; TCGA ESCA -0.503; TCGA HNSC -0.211; TCGA KIRP -0.471; TCGA LGG -0.1; TCGA LIHC -0.684; TCGA LUAD -0.174; TCGA SARC -0.332; TCGA THCA -0.496; TCGA UCEC -0.315
hsa-miR-101-3p
SOX11
12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUSC; OV; PAAD; STAD
miRNATAP
TCGA BLCA -0.571; TCGA BRCA -0.846; TCGA CESC -1.117; TCGA COAD -0.532; TCGA ESCA -1.049; TCGA HNSC -0.872; TCGA LGG -0.416; TCGA LIHC -1.103; TCGA LUSC -0.712; TCGA OV -0.961; TCGA PAAD -1.171; TCGA STAD -0.733
hsa-miR-101-3p
AP1S3
9 cancers: BRCA; CESC; COAD; KIRC; KIRP; LIHC; PAAD; THCA; UCEC
miRNAWalker2 validate
TCGA BRCA -0.132; TCGA CESC -0.166; TCGA COAD -0.286; TCGA KIRC -0.221; TCGA KIRP -0.408; TCGA LIHC -0.275; TCGA PAAD -0.455; TCGA THCA -0.133; TCGA UCEC -0.412
hsa-miR-101-3p
CDC7
13 cancers: BRCA; COAD; ESCA; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.224; TCGA COAD -0.169; TCGA ESCA -0.218; TCGA LGG -0.13; TCGA LIHC -0.619; TCGA LUAD -0.099; TCGA LUSC -0.349; TCGA OV -0.184; TCGA PRAD -0.176; TCGA SARC -0.183; TCGA THCA -0.132; TCGA STAD -0.265; TCGA UCEC -0.193
hsa-miR-101-3p
E2F3
10 cancers: BRCA; CESC; ESCA; LGG; LIHC; LUAD; LUSC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.178; TCGA CESC -0.132; TCGA ESCA -0.238; TCGA LGG -0.073; TCGA LIHC -0.408; TCGA LUAD -0.08; TCGA LUSC -0.25; TCGA THCA -0.053; TCGA STAD -0.202; TCGA UCEC -0.153
hsa-miR-101-3p
EZH2
10 cancers: BRCA; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC; UCEC
miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP
TCGA BRCA -0.277; TCGA KIRP -0.343; TCGA LGG -0.384; TCGA LIHC -0.759; TCGA LUAD -0.179; TCGA LUSC -0.666; TCGA OV -0.193; TCGA PAAD -0.238; TCGA SARC -0.234; TCGA UCEC -0.315
hsa-miR-101-3p
MRPL42
9 cancers: BRCA; COAD; ESCA; KIRC; LGG; LIHC; LUAD; LUSC; STAD
miRNAWalker2 validate; MirTarget
TCGA BRCA -0.15; TCGA COAD -0.181; TCGA ESCA -0.171; TCGA KIRC -0.131; TCGA LGG -0.098; TCGA LIHC -0.052; TCGA LUAD -0.058; TCGA LUSC -0.206; TCGA STAD -0.124
hsa-miR-101-3p
MSH2
9 cancers: BRCA; CESC; ESCA; KIRC; LIHC; LUAD; LUSC; OV; STAD
miRNAWalker2 validate
TCGA BRCA -0.117; TCGA CESC -0.081; TCGA ESCA -0.179; TCGA KIRC -0.091; TCGA LIHC -0.37; TCGA LUAD -0.06; TCGA LUSC -0.255; TCGA OV -0.078; TCGA STAD -0.168
hsa-miR-101-3p
MTSS1L
10 cancers: BRCA; COAD; ESCA; LGG; LUSC; PAAD; PRAD; SARC; THCA; STAD
miRNAWalker2 validate; MirTarget; miRNATAP
TCGA BRCA -0.085; TCGA COAD -0.161; TCGA ESCA -0.263; TCGA LGG -0.059; TCGA LUSC -0.131; TCGA PAAD -0.297; TCGA PRAD -0.087; TCGA SARC -0.292; TCGA THCA -0.138; TCGA STAD -0.268
hsa-miR-101-3p
NOP2
11 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.092; TCGA CESC -0.091; TCGA ESCA -0.201; TCGA HNSC -0.126; TCGA KIRP -0.204; TCGA LGG -0.114; TCGA LIHC -0.172; TCGA LUAD -0.111; TCGA LUSC -0.412; TCGA STAD -0.206; TCGA UCEC -0.088
hsa-miR-101-3p
RAC1
12 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; PAAD; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate; MirTarget
TCGA BRCA -0.14; TCGA ESCA -0.118; TCGA HNSC -0.087; TCGA KIRC -0.081; TCGA KIRP -0.14; TCGA LIHC -0.161; TCGA LUSC -0.12; TCGA PAAD -0.256; TCGA PRAD -0.091; TCGA THCA -0.054; TCGA STAD -0.123; TCGA UCEC -0.069
hsa-miR-101-3p
VEGFA
10 cancers: BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.245; TCGA CESC -0.44; TCGA ESCA -0.335; TCGA HNSC -0.281; TCGA LGG -0.179; TCGA LUAD -0.185; TCGA LUSC -0.202; TCGA PAAD -0.303; TCGA STAD -0.235; TCGA UCEC -0.131
hsa-miR-101-3p
MLEC
9 cancers: BRCA; CESC; HNSC; LIHC; OV; SARC; THCA; STAD; UCEC
MirTarget; miRNATAP
TCGA BRCA -0.065; TCGA CESC -0.187; TCGA HNSC -0.053; TCGA LIHC -0.198; TCGA OV -0.072; TCGA SARC -0.098; TCGA THCA -0.175; TCGA STAD -0.282; TCGA UCEC -0.115
hsa-miR-101-3p
RCN2
11 cancers: BRCA; CESC; COAD; ESCA; KIRC; LIHC; LUSC; OV; PRAD; SARC; STAD
MirTarget
TCGA BRCA -0.148; TCGA CESC -0.098; TCGA COAD -0.153; TCGA ESCA -0.165; TCGA KIRC -0.216; TCGA LIHC -0.244; TCGA LUSC -0.258; TCGA OV -0.166; TCGA PRAD -0.08; TCGA SARC -0.119; TCGA STAD -0.192
hsa-miR-101-3p
RAB15
9 cancers: BRCA; KIRC; LIHC; LUSC; OV; PAAD; SARC; THCA; UCEC
MirTarget
TCGA BRCA -0.082; TCGA KIRC -0.67; TCGA LIHC -0.279; TCGA LUSC -0.15; TCGA OV -0.168; TCGA PAAD -0.237; TCGA SARC -0.63; TCGA THCA -0.167; TCGA UCEC -0.145
hsa-miR-101-3p
SMARCA4
10 cancers: BRCA; CESC; ESCA; KIRC; LGG; LIHC; LUSC; PAAD; THCA; UCEC
MirTarget; miRNATAP
TCGA BRCA -0.065; TCGA CESC -0.095; TCGA ESCA -0.131; TCGA KIRC -0.109; TCGA LGG -0.136; TCGA LIHC -0.313; TCGA LUSC -0.164; TCGA PAAD -0.159; TCGA THCA -0.093; TCGA UCEC -0.212
hsa-miR-101-3p
STX6
9 cancers: BRCA; ESCA; HNSC; LGG; LIHC; LUSC; PRAD; THCA; UCEC
MirTarget
TCGA BRCA -0.178; TCGA ESCA -0.262; TCGA HNSC -0.189; TCGA LGG -0.076; TCGA LIHC -0.335; TCGA LUSC -0.232; TCGA PRAD -0.061; TCGA THCA -0.07; TCGA UCEC -0.179
hsa-miR-101-3p
TMEM68
9 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; OV; STAD
MirTarget
TCGA BRCA -0.087; TCGA ESCA -0.162; TCGA HNSC -0.074; TCGA KIRC -0.259; TCGA KIRP -0.089; TCGA LIHC -0.147; TCGA LUSC -0.16; TCGA OV -0.105; TCGA STAD -0.182
hsa-miR-101-3p
ZBED4
10 cancers: BRCA; CESC; ESCA; LGG; LIHC; LUSC; SARC; THCA; STAD; UCEC
MirTarget; miRNATAP
TCGA BRCA -0.093; TCGA CESC -0.13; TCGA ESCA -0.164; TCGA LGG -0.089; TCGA LIHC -0.187; TCGA LUSC -0.179; TCGA SARC -0.187; TCGA THCA -0.1; TCGA STAD -0.152; TCGA UCEC -0.195
hsa-miR-101-3p
GDE1
9 cancers: BRCA; KIRC; KIRP; OV; PAAD; PRAD; THCA; STAD; UCEC
MirTarget
TCGA BRCA -0.097; TCGA KIRC -0.352; TCGA KIRP -0.113; TCGA OV -0.129; TCGA PAAD -0.232; TCGA PRAD -0.055; TCGA THCA -0.192; TCGA STAD -0.141; TCGA UCEC -0.166
hsa-miR-101-3p
CCNJ
9 cancers: BRCA; CESC; KIRC; LGG; LIHC; LUAD; OV; STAD; UCEC
MirTarget; miRNATAP
TCGA BRCA -0.148; TCGA CESC -0.137; TCGA KIRC -0.16; TCGA LGG -0.123; TCGA LIHC -0.21; TCGA LUAD -0.094; TCGA OV -0.154; TCGA STAD -0.198; TCGA UCEC -0.197
hsa-miR-101-3p
IQGAP3
11 cancers: BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; SARC; UCEC
MirTarget
TCGA BRCA -0.431; TCGA CESC -0.152; TCGA ESCA -0.373; TCGA HNSC -0.118; TCGA LGG -0.325; TCGA LIHC -1.187; TCGA LUAD -0.199; TCGA LUSC -0.976; TCGA PAAD -0.727; TCGA SARC -0.423; TCGA UCEC -0.554
hsa-miR-101-3p
CENPO
15 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC
mirMAP
TCGA BRCA -0.282; TCGA CESC -0.155; TCGA ESCA -0.302; TCGA HNSC -0.179; TCGA KIRC -0.319; TCGA LGG -0.106; TCGA LIHC -0.485; TCGA LUAD -0.184; TCGA LUSC -0.443; TCGA OV -0.232; TCGA PAAD -0.198; TCGA SARC -0.243; TCGA THCA -0.15; TCGA STAD -0.176; TCGA UCEC -0.246
hsa-miR-101-3p
SIX4
9 cancers: BRCA; COAD; KIRC; LGG; LIHC; LUSC; PAAD; THCA; UCEC
miRNATAP
TCGA BRCA -0.149; TCGA COAD -0.51; TCGA KIRC -1.838; TCGA LGG -0.143; TCGA LIHC -0.897; TCGA LUSC -0.476; TCGA PAAD -0.999; TCGA THCA -0.314; TCGA UCEC -0.16
hsa-miR-101-3p
ONECUT2
9 cancers: BRCA; COAD; KIRC; KIRP; LGG; LUSC; SARC; THCA; UCEC
miRNATAP
TCGA BRCA -0.628; TCGA COAD -0.48; TCGA KIRC -1.602; TCGA KIRP -0.823; TCGA LGG -0.17; TCGA LUSC -0.761; TCGA SARC -0.334; TCGA THCA -0.192; TCGA UCEC -0.254
hsa-miR-101-3p
XPR1
10 cancers: BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; SARC; THCA; STAD
miRNATAP
TCGA BRCA -0.123; TCGA CESC -0.153; TCGA COAD -0.12; TCGA ESCA -0.45; TCGA HNSC -0.169; TCGA LIHC -0.176; TCGA LUSC -0.303; TCGA SARC -0.19; TCGA THCA -0.268; TCGA STAD -0.135
hsa-miR-101-3p
ANKRD52
11 cancers: BRCA; CESC; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; SARC; THCA; STAD
miRNATAP
TCGA BRCA -0.062; TCGA CESC -0.183; TCGA COAD -0.116; TCGA ESCA -0.19; TCGA KIRC -0.168; TCGA LIHC -0.498; TCGA LUAD -0.106; TCGA LUSC -0.161; TCGA SARC -0.139; TCGA THCA -0.114; TCGA STAD -0.263
hsa-miR-101-3p
HAPLN1
12 cancers: BRCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA; UCEC
miRNATAP
TCGA BRCA -0.855; TCGA CESC -0.778; TCGA HNSC -0.672; TCGA KIRP -0.526; TCGA LGG -0.24; TCGA LIHC -0.749; TCGA LUAD -0.342; TCGA LUSC -0.337; TCGA PAAD -1.153; TCGA SARC -0.817; TCGA THCA -0.352; TCGA UCEC -0.623
hsa-miR-101-3p
NANOS1
10 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; OV; PRAD; STAD
miRNATAP
TCGA BRCA -0.144; TCGA HNSC -0.108; TCGA KIRC -0.258; TCGA KIRP -0.123; TCGA LGG -0.06; TCGA LIHC -0.183; TCGA LUSC -0.121; TCGA OV -0.239; TCGA PRAD -0.095; TCGA STAD -0.244
hsa-miR-101-3p
AMMECR1
10 cancers: BRCA; ESCA; HNSC; KIRC; LIHC; LUSC; OV; SARC; THCA; UCEC
miRNATAP
TCGA BRCA -0.174; TCGA ESCA -0.418; TCGA HNSC -0.136; TCGA KIRC -0.25; TCGA LIHC -0.11; TCGA LUSC -0.291; TCGA OV -0.123; TCGA SARC -0.147; TCGA THCA -0.064; TCGA UCEC -0.158
hsa-miR-101-3p
TEAD3
9 cancers: BRCA; ESCA; KIRC; LIHC; LUSC; PAAD; PRAD; SARC; STAD
miRNATAP
TCGA BRCA -0.061; TCGA ESCA -0.235; TCGA KIRC -0.176; TCGA LIHC -0.183; TCGA LUSC -0.233; TCGA PAAD -0.546; TCGA PRAD -0.064; TCGA SARC -0.346; TCGA STAD -0.263
hsa-miR-101-3p
NACC1
15 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC
miRNATAP
TCGA BRCA -0.099; TCGA CESC -0.193; TCGA COAD -0.154; TCGA ESCA -0.227; TCGA HNSC -0.157; TCGA KIRC -0.153; TCGA LIHC -0.209; TCGA LUAD -0.094; TCGA LUSC -0.287; TCGA PAAD -0.288; TCGA PRAD -0.124; TCGA SARC -0.13; TCGA THCA -0.173; TCGA STAD -0.202; TCGA UCEC -0.179
hsa-miR-101-3p
NDRG4
10 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; OV; THCA
miRNATAP
TCGA BRCA -0.144; TCGA COAD -0.297; TCGA ESCA -0.578; TCGA HNSC -0.274; TCGA KIRC -0.442; TCGA KIRP -0.507; TCGA LIHC -0.276; TCGA LUAD -0.277; TCGA OV -0.211; TCGA THCA -0.249
hsa-miR-101-3p
E2F8
9 cancers: BRCA; LGG; LIHC; LUAD; LUSC; PRAD; SARC; THCA; UCEC
miRNATAP
TCGA BRCA -0.492; TCGA LGG -0.475; TCGA LIHC -0.924; TCGA LUAD -0.166; TCGA LUSC -0.745; TCGA PRAD -0.238; TCGA SARC -0.363; TCGA THCA -0.29; TCGA UCEC -0.428
hsa-miR-101-3p
SMARCD1
9 cancers: CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; UCEC
miRNAWalker2 validate; MirTarget; miRNATAP
TCGA CESC -0.071; TCGA ESCA -0.159; TCGA HNSC -0.08; TCGA KIRP -0.112; TCGA LGG -0.121; TCGA LIHC -0.271; TCGA LUAD -0.076; TCGA LUSC -0.191; TCGA UCEC -0.06
hsa-miR-101-3p
LRRC14
10 cancers: CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; STAD
mirMAP
TCGA CESC -0.07; TCGA HNSC -0.082; TCGA KIRP -0.108; TCGA LGG -0.092; TCGA LIHC -0.335; TCGA LUAD -0.076; TCGA LUSC -0.206; TCGA PAAD -0.149; TCGA SARC -0.109; TCGA STAD -0.162
hsa-miR-101-3p
CA12
12 cancers: COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; PAAD; SARC; THCA; STAD; UCEC
mirMAP
TCGA COAD -0.377; TCGA ESCA -0.924; TCGA HNSC -0.321; TCGA KIRC -0.351; TCGA LGG -0.215; TCGA LIHC -1.219; TCGA LUSC -0.889; TCGA PAAD -0.95; TCGA SARC -0.728; TCGA THCA -0.343; TCGA STAD -0.452; TCGA UCEC -0.423
hsa-miR-101-3p
GMEB2
9 cancers: ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; STAD
miRNAWalker2 validate
TCGA ESCA -0.128; TCGA HNSC -0.076; TCGA KIRP -0.082; TCGA LGG -0.053; TCGA LIHC -0.15; TCGA LUAD -0.111; TCGA LUSC -0.2; TCGA PAAD -0.173; TCGA STAD -0.139





Enriched cancer pathways of putative targets